Thursday, March 30, 2017
ACADIA Pharmaceuticals Names New Chief Commercial Officer
San Diego-based biopharmaceuticals developer ACADIA Pharmaceuticals announced this morning that it has named Michael J. Yang as the company's new Executive Vice President and Chief Commercial Officer. Yang replaces former Chief Commercial Officer Terrence O. Moore, who the company says is retiring. Yang was previously President of Janssen Biotech, and also had served at Johnson & Johnson, Therakos, Veridex, and Ortho Biotech. ACADIA is developing treatments for central nervous system (CNS) disorders.